Cambrian BioPharma Inc, 10% Owner at Sensei Biotherapeutics, Inc. (SNSE), bought 30,000 shares at $4.45 ($136K) on 2022-02-04, disclosed to the SEC on 2022-02-08.
Open-market purchase of $136k SNSE by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.65 | 17,500 | $81K | 59.9% |
| 2 | $4.45 | 2,500 | $11K | 8.2% |
| 3 | $4.33 | 10,000 | $43K | 31.9% |
| Total | $4.53 avg | 30,000 | $136K | 100% |
| Filing → |
| SNSE | SELL | 2025-12-08 | $398K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $136K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $15K | — | Filing → |